Common Stock, Shares, Issued of Nabriva Therapeutics plc from Q4 2016 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nabriva Therapeutics plc quarterly Common Stock, Shares, Issued history and change rate from Q4 2016 to Q2 2023.
  • Nabriva Therapeutics plc Common Stock, Shares, Issued for the quarter ending 30 Jun 2023 was 3.23M shares, a 95% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Nabriva Therapeutics plc Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 3.23M -61.3M -95% 30 Jun 2023 10-Q 19 Oct 2023
Q1 2023 3.2M -58.5M -94.8% 31 Mar 2023 10-Q 22 May 2023
Q4 2022 3.2M +933K +41.1% 31 Dec 2022 10-Q 19 Oct 2023
Q3 2022 3.02M -51.3M -94.4% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 64.6M +14.8M +29.8% 30 Jun 2022 10-Q 03 Aug 2022
Q1 2022 61.7M +26.3M +74.3% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 2.27M -18.8M -89.2% 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 54.3M -95.7M -63.8% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 49.7M -93.2M -65.2% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 35.4M -59.7M -62.8% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 21.1M +11.6M +123% 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 150M +72M +92.3% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 143M +70.1M +96.1% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 95.1M +23.8M +33.3% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 9.45M -57.6M -85.9% 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 78M +11.5M +17.3% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 72.9M +31.9M +78% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 71.3M +31.1M +77.3% 31 Mar 2019 10-Q 10 May 2019
Q4 2018 67M +30.3M +82.6% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 66.5M 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 41M 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 40.2M 31 Mar 2018 10-Q 08 May 2018
Q4 2017 36.7M +34M +1250% 31 Dec 2017 10-K 12 Mar 2019
Q4 2016 2.72M 31 Dec 2016 10-K 16 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.